United States· US:83819-608_6dc592df-ae5b-4685-bd42-fde9abd99d46
dermveda SINAFLUX ULTRA NATURAL SINUS RELIEF
A medicinal product containing melaleuca alternifolia whole; glycyrrhiza glabra (licorice) root powder, registered in United States by Celcius Corp..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MELALEUCA ALTERNIFOLIA WHOLE; GLYCYRRHIZA GLABRA (LICORICE) ROOT POWDER
- Manufacturer
- Celcius Corp.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1183819-608-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddfa9e7a-743f-494a-8220-6263d41e194f GET /v1/drugs/ddfa9e7a-743f-494a-8220-6263d41e194f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "NASAL",
"source": "ndc",
"strength": "8; 10",
"substance": "MELALEUCA ALTERNIFOLIA WHOLE; GLYCYRRHIZA GLABRA (LICORICE) ROOT POWDER",
"productndc": "83819-608",
"dosage_form": "SPRAY",
"dea_schedule": null,
"strength_unit": "[hp_X]/30mL; [hp_X]/30mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about melaleuca alternifolia whole; glycyrrhiza glabra (licorice) root powder.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.